Clinical trials
Leukemia, Myelomonocytic, Chronic trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| AbbVie | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Kirsten Grønbæk | 1 |
| Nanexa AB | 1 |
| Nordic MDS Group | 1 |
| Novartis Pharmaceuticals | 1 |
| Traws Pharma, Inc. | 1 |
| Vastra Gotaland Region | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 10 |
| Myelodysplastic Syndromes | 7 |
| Leukemia, Myeloid, Acute | 4 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Neoplasms | 2 |
| Polycythemia Vera | 2 |
| Primary Myelofibrosis | 2 |
| Thrombocythemia, Essential | 2 |
| Anemia, Refractory | 1 |
| Blast Crisis | 1 |
Trials
Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.